4'-Ethynyl-4-n- [2,lpropylbicycloorthobenzoate (13HlEBOB) EBOB binds to the picrotoxin binding site associated with the GABA, receptor complex, that regional differences in GABA, agonist and antagonist modulation of [3H]EBOB binding reflect underlying regional differences in GABA, receptor subunit composition, and that there is a species difference in GABA, receptor distribution between human and rat cerebellum.
Introduction
The GABA, receptor is the major mediator of synaptic inhibition in the central nervous system and structurally is a hetero-oligomeric protein comprised of five (or fewer) subunits per active complex (Burt and Kamatchi, 1991) . Molecular cloning studies have provided evidence for the existence of a number of different subunits forming the GABA, receptor and each of these subunits has a distinct regional distribution in the brain (Olsen and Tobin, 1990; Burt and Kamatchi, 1991;  Among the several binding sites of the GABA, receptor complex, a site of particular interest is the picrotoxin site. In binding studies, picrotoxin ligand binding is regulated by the activation of other sites on the GABA, receptor complex. GABA, agonists and zinc inhibit picrotoxin ligand binding (Squires et al., 1983; Lawrence et al., 1985; Edgar and Schwartz, 1990; Kume et al., 1994; Sakurai et al., 1994) . Benzodiazepines and neurosteroids have complex effects (Gee et al., 1986 (Gee et al., , 1988 (Gee et al., , 1989 Lloyd et al., 1990; Im and Blakeman, 1991; Concas et al., 1990; Sakurai et al., 1994) . The regulation of picrotoxin ligand binding by other sites on the GABA, receptor complex allows picrotoxin ligand binding assays to be used as functional probes of GABA, receptor function and pharmacology.
The picrotoxin site on the GABA, receptor complex has been characterized with [ 3H]a-dihydropicrotoxinin (Ticku et al., 19781, [ 35S] t-butylbicyclophosphorothionate ([35S] TBPS> (Lawrence and Casida, 1983; Squires et al., 1983; Ramanjaneyulu and Ticku, 1984; Edgar and Schwartz, 1990) (Lawrence et al., 1985; Van Rijn et al., 1990; Sakurai et al., 1994 Deng et al., 1991; Cole and Casida, 1992; Hawkinson and Casida, 1992) . EBOB is structurally related to TBOB. The specific binding is approximately 90% of total binding and the reported K d of [3H] EBOB is approximately 2 nM which is almost one tenth of that of [3H]TBOB (Cole and Casida, 1992 
Materials and methods

Subjects
Male Sprague-Dawley rats (Harlan Labs, Indianapolis, IN, USA; weight, 175-199 g) were decapitated, their brains rapidly removed, mounted on cryotome chunks, and frozen in Lipshaw embedding matrix surrounded by powdered dry ice. 20 /zm-thick sections were cut in the horizontal plane on a Lipshaw cryostat. Sections were obtained at the level including the caudo-putamen, and thaw-mounted onto 2 x subbed gelatin-coated slides on a warming plate and stored at -20°C until the time of assay. All assays were performed 24 h after decapitation. Each experiment was run in triplicate.
Six human cerebellar hemispheres from individuals without neurologic diseases were obtained at necropsy, sectioned in a sagittal plane into 1 cm slabs, frozen in crushed dry ice, placed in sealed plastic bags, and stored at -70°C. The average postmortem delay to storage was 17.2 h (range, 7-23 h), and the average age at death was 49.3 years (range, 24-80 years) . At the time of assay, slabs were warmed overnight to -20°C and blocks containing the cerebellar cortex were cut out of the slabs. Blocks were mounted on cryotome chunks, and 20/~m-thick sections were cut sagittally on a Lipshow cryostat. Sections were thaw-mounted onto 2 x subbed gelatin-coated slides and stored at -20°C until assay. Assays were run 24 h after sectioning.
[3H]EBOB binding
Slide-mounted tissue sections were warmed to room temperature and prewashed for 3 x 10 min in buffer (50 mM Tris-HCl + 1 mM EDTA pH 7.4 at 4°C) and dried under a stream of cool air. Binding of [3H]EBOB (2 nM) was carried out in buffer (50 mM Tris-HCl + 120 mM NaC1 pH 7.4 at room temperature) for 120 min at room temperature. The incubation was terminated by two 60 min rinses in buffer (50 mM Tris-HCl pH 7.4 at 4°C) at 4°C followed by a brief dip in distilled water. Each slide was then dried under a stream of hot air. Non-specific binding was assessed in the presence of 20 /zM picrotoxin. Autoradiograms were generated by apposing the slides to tritium-sensitive film (Hyperfilm, Amersham) in light-tight cassettes along with standards containing known amounts of radioactivity. After 3 weeks, films were developed in Kodak D-19. Ligand binding was quantitated with computer-assisted densitometry using the MCID system (Imaging Research, St. Catherines, Ontario, Canada). To quantify ligand binding density, the optical density of co-exposed standards was determined and a standard curve generated by fitting standard values with a fourth-degree polynomial regression equation. Standards were commercial 14C plastic standards (ARC, St. Louis, MO, USA). Use of the standards and derived standard curve allows conversion of areal optical density to pmol/mg protein values. Areas read included the cortical laminae I-III, lamina IV and laminae V-VI, hippocampal CA1 stratum oriens, CA1 stratum radiatum, CA3 stratum oriens, CA3 stratum radiatum and dentate gyrus, striatum, thalamus (laterodorsal thalamic nucleus and lateral posterior thalamic nucleus), septum, superior colliculus, inferior colliculus, periaqueductal gray matter, and cerebellar molecular and granule cell layers. Ten to twenty readings per area from triplicate sections were averaged.
Optimal prewashing was determined by using 2 different prewashing regimens: 3 x 10 min washed in 50 mM Tris-HCl (pH 7.4 at 4°C), 3 x 10 min washes in 50 mM Tris-HCl + 1 mM EDTA (pH 7.4 at 4°C). Sections were then processed as described above using 2 nM [3H]EBOB.
For association experiments, sections were incubated in assay buffer containing 2 nM [3H]EBOB for 12 time points between 2 and 360 min, and rinsed as described above.
For saturation studies, sections were incubated in 10 concentrations of [3H]EBOB ranging from 10 pM to 10 nM. Non-specific binding was assessed with addition of 200/zM picrotoxin. Films were analyzed as described above and data further analyzed with Scatchard plots.
Effects of picrotoxin, isoguvacine and bicuculline
To determine the regulation of [3H]EBOB binding by GABA A ligands, unlabelled drugs were included in the incubation mixture with 2 nM [3H]EBOB. Drugs evaluated included: 1 nM to 10 ~M picrotoxin, 1 nM to 100 /xM isoguvacine, 1 /xM to 1 mM bicuculline methobromide. IC50 values for competitors were calculated by log-logit analysis. The interaction of picrotoxin with [3H]EBOB was further examined by performing saturation analysis as described above in the presence of 600 nM picrotoxin.
Regional distribution of [3H]EBOB binding sites
The regional distribution of [3H]EBOB binding sites was established using horizontal sections cut at the level including the caudo-putamen. Sections were processed for [3H]EBOB autoradiography as described above using 2 nM [3H]EBOB. We compared the regional distribution of [3H]EBOB with that of [3H]-TBOB.
[3H]TBOB autoradiography was performed as described previously Sakurai et al., 1994) Sakurai et al., 1994 ) using 20 nM [3H]TBOB. In generating autoradiograms, sections were exposed to tritiumsensitive film for 5 weeks. sham (Arlington Heights, IL, USA). Isoguvacine was purchased from Cambridge Research Biochemicals (Cambridge, UK). Bicuculline and picrotoxin were purchased from Research Biochemicals (Natick, MA, USA). The remaining reagents were purchased from Sigma Chemicals (St. Louis, MO, USA) and were of the highest possible purity.
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Results
[SH]EBOB binding
Prewashing in buffer containing 1 mM EDTA provided specific [3H]EBOB binding of 1.13 + 0.077 pmol/mg protein (mean + S.E.M.) in cortical lamina IV, which is 1.5 times as high as that prewashed in buffer without EDTA. Therefore, in all experiments slices were prewashed in buffer containing 1 mM EDTA. Specific binding of [3H]EBOB was 99% of total binding when sections received 2 × 60 min rinses in 50 mM Tris-HCl (pH 7.4 at 4°C).
In association experiments, specific [3H]EBOB binding increased with increasing incubation time and steady state was reached by 2 h of incubation at room temperature ( Fig. 1) . Specific binding was stable at incubation times up to 4 h but declined variably after longer incubation times, apparently due to degeneration of the slide-mounted tissue. Therefore, slices were incubated with [3H]EBOB for 2 h in equilibrium-binding experiments.
Saturation experiments showed that specific [3H]-EBOB binding sites were occupied with 7 nM [3H]-EBOB ( Fig. 2A) . Non-specific binding was linear over the range of [3H]EBOB concentrations used and the percentage of non-specific binding was 3-6% of total binding at 2 nM. Scatchard plot was well fitted to a simple linear regression (r = -0.923, P < 0.001) and n H approximated 1 (Fig. 2B) , indicating a single population of binding sites. The binding parameters from experiments with 3 animals yielded a g d of 4.59 _ 0.47 nM and Bma x of 4.83 _+ 0.13 pmol/mg protein (mean _ S.E.M.) in cortical lamina IV.
Effects of picrotoxin, isoguvacine and bicuculline
Compounds which modulate the activity of the GABA A receptor complex modulated binding of [3H]EBOB. Picrotoxin produced dose-dependent inhibition with an ICs0 of 600 nM and saturation analysis performed in the presence of 600 nM picrotoxin indicated a competitive interaction (Figs. 2B, 3, and 4). The n H for picrotoxin was 1.40 -t-0.04 (mean +_ S.E.M) and significantly greater than 1 (P < 0.0005 on t-test). The GABA g agonist, isoguvacine, also produced dosedependent inhibition of [3H]EBOB binding in all areas examined, but there were regional differences in isogu-A aa~. ICs0 values for isoguvacine were significantly different among brain regions (P < 0.0001 on ANOVA, Table 1) with ICs0 values lowest in cortical laminae I-III, hippocampal CA1 stratum radiatum and dentate gyrus, septum and the cerebellar molecular and granule cell layers. Relatively low ICs0 values were observed also in cortical laminae IV, thalamus, inferior colliculus and periaqueductal gray matter. Relatively high ICs0 values were found in cortical laminae V-VI, hippocampal CA1 stratum oriens and CA3 stratum oriens, striatum and superior colliculus. Bicuculline produced a regionally specific increase in [3H]EBOB binding that was restricted to the cerebellar granule cell layer. The enhancement of binding by bicuculline was greater in the inner zone of the granule cell layer than in the outer zone of the granule cell layer. In this experiment, we paid particular attention to the regional heterogeneity of allosteric modulation of [3H]EBOB binding in the cerebellar granule cell layer and carefully analyzed the autoradiographs (Fig. 5 ). In the presence of 50 /zM bicuculline, the enhancement of binding was 90% in the outer zone and 244% in the inner zone of the granule cell layer. Significant difference in the enhancement by bicuculline was noted between the two zones (P < 0.05 on t-test). Such zonally different modulation of [3H]EBOB binding in the granule cell layer was found to some extent in experiments prewashed in buffer without EDTA, but not in inhibition experiments with picrotoxin. In sections prewashed in buffer without EDTA, [3H]EBOB binding in the molecular layer and outer granule cell layer was reduced relative to binding in the granule cell layer bordering the white matter.
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Regional distribution of [ 3H]EBOB binding sites
The regional distribution of [3H]EBOB binding sites was heterogeneous (Table 2) . High levels of binding were found in lamina IV of neocortex, the pre/parasubiculum of the hippocampal formation; intermediate levels of binding were found in laminae I-III of neocortex, laminae V-VI of neocortex, most areas of hippocampal formation, superior colliculus, inferior colliculus, periaqueductal gray matter, the cerebellar molecular layer; and low levels of binding in septum, striatum, thalamus, the cerebellar granule cell layer. This distribution pattern was virtually identical with that of [3H]TBOB binding sites. Correlation of the regional distribution of [3H]EBOB binding sites with the regional distribution of [3H]TBOB binding sites revealed significant correlation (Fig. 6 ).
Highest levels of binding were seen in the granule cell layer bordering the white matter (0.62 + 0.044 pmol/ mg protein) and specific binding was 94% of total binding. 
Human cerebellar cortex
Discussion
Specific [3H]EBOB binding sites were found within the human cerebellar cortex (Fig. 7) . The distribution of binding sites was heterogeneous, with higher levels of binding in the granule cell layer (mean 0.44 + 0.026 (S.E.M.) pmol/mg protein) and lower levels in the molecular layer (0.060 + 0.0086 pmol/mg protein).
[3H]EBOB binding
[3H]EBOB is a suitable radioligand for quantitative autoradiography of picrotoxin binding sites. The EDTA prewash has been shown to be more efficient in removing endogeneous tissue GABA than conventional pre- ICs0 values were derived from inhibition curves with isoguvacine. Data are mean + S.E.M. values from experiments with n = 3 animals. A significant difference of the IC50 values among regions is noted on one-way ANOVA (P < 0.0001). (Squires et al., 1983; Edgar and Schwartz, 1990) , 2-to 10-fold lower than those of [3H]TBOB (Lawrence et al., 1985; Van Rijn et al., 1990 ) and virtually 6-fold lower than those of [3H]TBOB obtained previously in our laboratory Sakurai et al., 1994 (Edgar and Schwartz, 1990; Sapp et al., 1992) and [3H]TBOB autoradiography . Likewise, EDTA prewash is necessary for optimal [3H]EBOB autoradiography. In homogenate studies, investigators have used incubation times ranging from 60 to 90 min, but the time to reach equilibrium was not indicated. Our association experiments indicate that an incubation time of 2 h is necessary for [3H]EBOB binding to slices to reach equilibrium.
EBOB is 4-to 5-fold lower than those of [35S]TBPS
The affinity of [3H]EBOB for slide-mounted sections was determined according to saturation analysis; K d = 4.59 + 0.47 nM in cortical lamina IV. Our observed K d values are somewhat higher than that found in the homogenate binding using animal and human brains (Cole and Casida, 1992; Hawkinson and Casida, 1992) tative autoradiography. First, a proper rinse provides an optimal autoradiographic image with a high contrast to the background because specific, high-affinity binding dissociates little while most of non-specific binding 
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Effects of picrotoxin, isoguvacine and bicuculline
Previous binding studies have indicated that unlabeled EBOB inhibits [35S]TBPS binding to the picrotoxin site (Hawkinson and Casida, 1992) and [3H]EBOB binding is inhibited by a number of unlabeled compounds acting at the picrotoxin site, such as picrotoxin, lindane, TBPS and dithianes (Dens et al., 1991; Cole and Casida, 1992) . Scatchard analysis demonstrated that lindane and picrotoxin are competitive inhibitors of [3H]EBOB binding in the insect brain (Dens et al., 1991) . In the present study, we observed that [3H]-EBOB binding to the rat brain slices is inhibited by picrotoxin in a competitive manner. Our results sup-port the conclusion that [3H]EBOB binds to the picrotoxin site associated with the GABA A receptor complex.
We observed regional differences in allosteric effect by GABA A compounds on [3H]EBOB binding. Isoguvacine, a GABA A agonist, inhibited [3H]EBOB binding in all brain regions but there was a regional difference in inhibitory effect by isoguvacine. Bicuculline, a GABA A antagonist, enchanced [3H]EBOB binding only to the cerebellar granule cell layer while picrotoxin uniformly inhibited its binding. Regionally different effects of allosteric modulators on picrotoxin ligand binding have been reported with [35S]TBPS and [3H]-TBOB (Gee et al., 1988; Sapp et al., 1992; Korpi et al., 1992; Korpi and Liiddens, 1993; Kume et al., 1994; Sakurai et al., 1994) . The pharmacological and molecular biological evidence for regional heterogeneity of the GABA A receptor complex has been widely reported and regional/cellular differences in the expression of GABA A receptor subunit isoforms probably underlie, at least in part, regional/cellular differences in receptor function and pharmacology (Olsen and Tobin, 1990; Burt and Kamatchi, 1991) . For example, the cerebellar granule cells have a unique collection of the GABA A receptor subunits (Shivers et al., 1989; Liiddens et al., 1990) and they are the single type of neuron expressing the a6 subunit in adult rat brain (Laurie et al., 1992a, b; Thompson et al., 1992) . Korpi and Liiddens (1993) correlated the GABA A pharmacology in rat brain sections with the properties of recombinant receptors expressed from various subunit cDNAs selected on the basis of their regional expression, and provided evidence that a greater GABA sensitivity of [35S]TBPS binding in the cerebellar granule ceils is inherent to a6 subunit-containing receptors. In this study, we observed bicuculline enchancement of [3H]EBOB binding only in the cerebellar granule cell layer. This property, a differential coupling of bicuculline sites and [3H]EBOB binding sites in cerebellar granule cells, is probably determined by the expression of a6 subunit conferring exceptional sensitivity to the effects of the small amount of GABA remaining in sections after prewashes (Korpi and Liiddens, 1993) . Thus, the regional difference in GABA A agonist/antagonist effects on [3H]EBOB binding may well reflect the regional heterogeneity of GABA A isoforms.
It is interesting that the cerebellar granule cell layer showed regional heterogeneity of GABA A agonist/ antagonist modulation of [3H]EBOB binding despite its anatomically homogeneous appearance. This was first noted by Edgar and Schwartz (1990) and confirmed by Korpi and Liiddens (1993 (al, a6, f12, /33, y2, 6) in the rat cerebellar granule cells and suggested the existence of at least two subtypes of pentameric GABA A receptors on the granule cells or subtypes of granule cells expressing different GABA A receptors (Laurie et al., 1992a) . A recent immunocytochemical study with antibodies for several GABA A receptor subunits on cultured cerebellar granule cells predict two subtypes of the GABA A receptor with heteropentameric structure (aa/3fly2, ototflfl8 -Caruncho et al., 1993) . The existence of 2 different subtypes of GABA A receptor in granule cells may bring about differential GABA and GABA antagonist effects on [3H]EBOB binding in the granule cell layer.
During development, granule cells are generated in the external granular layer of the cerebellum and migrate to their adult position where they will then elaborate dendrites which will become postsynaptic to the axon of the Golgi cells (Altman, 1972a,b; Rakic, 1971) . Golgi cells form inhibitory GABAergic synapses with granule cells in synaptic glomeruli (Palay and ChanPalay, 1974) . As granule cells enter the granule cell layer, they form an outside-to-inside gradient with the early generated cells settling superficial to the newly arriving cells. The developing granule cells express GABA A receptor subunits only after they have achieved their adult position and elaborated dendrites (Meinecke and Rakic, 1990; Gambarana et al., 1990; Laurie et al., 1992b; Zheng et al., 1993) . Therefore, in granule cells there probably exists some zonal difference of GABAergic synapse formation and expression of the GABA A receptor complex.
Regional distribution of [3H]EBOB binding sites
Reported regional distributions of picrotoxin ligand binding sites, such as [35S]TBPS and [3H]TBOB binding sites (Gee et al., 1983; Lawrence et al., 1985; Edgar and Schwartz, 1990; Sakurai et al., 1994) and [3H]2-oxo-quazepam suggested that regional expression of benzodiazepine type I binding and [3H]TBOB binding have common underlying determinants. Sakurai et al. (1994) found a number of similarities between regional distribution of [3H]TBOB binding sites and that of al subunit mRNA determined by in situ hybridization, and suggested that the presence of al subunit is an important determinant of [3H]TBOB binding.
Although homogenate binding experiments have indicated that TBPS and TBOB act at the same population of binding sites (Lawrence et al., 1985) , autoradiographic studies revealed that the regional distribution of [3H]TBOB binding sites was somewhat different from that of [35S]TBPS binding sites Sakurai et al., 1994) . In this experiment, we confirmed a similar discord of the distribution of ligand binding sites between [3H]EBOB autoradiography and previously reported [35S]TBPS autoradiography (Edgar and Schwartz, 1990; Kume et al., unpublished data) . TBPS, TBOB and EBOB are insecticides with a high toxicity and structurally consist of trioxabicyclooctane and X-substituents Casida, 1993; Hawkinson and Casida, 1993) . The structuretoxicity relationships of trioxabicyclooctanes has revealed a discontinuous size-activity correlation for the X-substituents, i.e., high toxicity is conferred by small and large substituents and low toxicity by those of intermediate size (Milbrath et al., 1979; Palmer and Casida, 1988) , and two distinct binding sites were therefore proposed: one for compounds with small X-substituents such as TBPS and one for trioxabicyclooctanes with large X-substituents such as TBOB and EBOB. The proposal of two subtypes of binding sites for trioxabicyclooctanes is consistent with our results of correlation analysis among [35S]TBPS, [3H]TBOB and [3H]EBOB binding sites. The hypothesis of subtypes of picrotoxin binding sites is also consistent with our picrotoxin competition data. The n H of the picrotoxin displacement curve was significantly greater than 1, which is consistent with the existence of multiple picrotoxin binding sites, although positive cooperativity between identical sites is also possible.
Human cerebellar cortex
Autoradiographic studies of the GABA A receptor complex in human cerebellum have reported localization of GABA and benzodiazepine binding sites in normal and diseased conditions (Young and Kuhar, 1979; Whitehouse et al., 1986; Albin and Gilman, 1990; Price et al., 1993 (Cole and Casida, 1992) . Those results are consistent with our data. The high affinity and high specific binding of [3H]EBOB make it possible to perform autoradiographic studies of picrotoxin binding sites in human brain.
We observed a species difference in distribution of [3H]EBOB binding sites. In rat cerebellum, there is a high density of [3H]EBOB binding sites in the molecular layer and a relatively low but significant density in the granule cell layer. In the human cerebellum, there was a high density of [3H]EBOB binding sites in the granule cell layer, but there was a markedly reduced level of binding sites in the molecular layer. Similar species difference in receptor distribution in the cerebellum is reported for the benzodiazepine site of the GABA A receptor complex (Young and Kuhar, 1979; Albin and Gilman, 1990 ), where human brain shows a high density of benzodiazepine site in association with both the molecular layer and the granule cell layer while in the rat cerebellum there is a high density in the molecular layer but a markedly reduced level in the granule cell layer. Species difference in receptor distribution may reflect species differences in GABA A receptors in the cerebellar cortex.
In addition, we observed a zonally arranged difference in the level of [3H]EBOB binding sites in the human cerebellar granule cell layer. The highest density was seen in the inner zone bordering the white matter. This finding is similar to that found in the rat cerebellar granule cell layer. As described above, we suppose some zonal difference in GABAergic synapse formation and expression of the GABA A receptor complex in the rat cerebellar granule cell layer. Like rat cerebellar granule cells, human granule cells are generated in the external granular layer of the cerebellum, migrate to their adult position and then mature (Rakic and Sidman, 1970) . A similar zonal difference of GABAergic synapse formation and expression of the GABA A receptor complex may underlie the zonally arranged difference in density of [3H]EBOB binding site in human cerebellar granule cells. their helpful advice, and Mr. C. Campbell for assistance with computer programs. This work was supported by NS19613 and AG08671 from the National Institutes of Health.
